Clinical heterogeneity and treatment optimization in anti-KLHL11 encephalitis: two case reports and literature review - Top-Institutions - MDSpire

Clinical heterogeneity and treatment optimization in anti-KLHL11 encephalitis: two case reports and literature review

  • By

  • Lin Han

  • Ying Li

  • Chuan Li

  • Lin Li

  • Dan Yao

  • Yunfeng Hao

  • Xuan Zhou

  • Yuting Dang

  • Rong Zhang

  • Lan Gao

  • Jun Luo

  • Jiaxin Yang

  • Ying Du

  • Wei Zhang

  • June 1, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Neurology
    • Autoimmune Neurology

  • #2

    University of California, San Francisco (UCSF) Health
    University of California, San Francisco (UCSF) Health

    San Francisco, California

    Key Differentiators

    • Neurology
    • Neuroimmunology

Original Source(s)

Clinical heterogeneity and treatment optimization in anti-KLHL11 encephalitis: two case reports and literature review

  • by Lin Han, Ying Li, Chuan Li, Lin Li, Dan Yao, Yunfeng Hao, Xuan Zhou, Yuting Dang, Rong Zhang, Lan Gao, Jun Luo, Jiaxin Yang, Ying Du, Wei Zhang

  • June 1, 2026

Related Content

The phosphoproteomic landscape of the neurological manifestations in tuberous sclerosis complex

A cell death program–based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma

Biomarkers for predicting immunotherapy response and resistance in glioblastoma